Abstract

Only a very small number of innovations in healthcare are ultimately market proof. Most innovations fail because they do not serve an actual market. Different models are available to provide guidance in the development phase of a novel therapy. One of these models is the V model, which was created to align development with stakeholders and to improve efficiency of development cycle. The alignment with stakeholders helps to insure the innovation matches the actual market. The models is very functional in pure technical and digital innovation, however the medical innovation is complex and not fully covered by this model. The novel V+ model introduce an additional layer to the V model, thereby covering all aspects of development in the medical landscape.